A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
Clinical trial NCT06375512 · COMPLETED
Trial details
- NCT number
- NCT06375512
- Sponsor
- Shenzhen Shenxin Biotechnology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2026-02-20
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.